Search

Choice of a medical or surgical method of termination for fetal anomaly (TFA) is advocated in national guidelines based on a similar risk profile. We investigated whether women are offered a choice of method, by surveying members of a UK parent support organisation. An online questionnaire was designed to examine respondents' experience of TFA. A total of 351 responses were included in the final analysis. TFAs after 24 weeks' gestation and selective reductions were excluded. Mean gestational age at TFA was 17 weeks; 14% (n = 50) were offered a choice of method, falling to 8% (n = 19) after 14 weeks' gestation. Overall, 78% (n = 275) underwent medical TFA with 88% stating they chose it because it was the only method offered; 60% (n = 30) of those offered a choice had a surgical TFA. Our survey suggests that women having TFA are not offered a choice of method. Service delivery should be improved to meet national guidance and women's needs. [ABSTRACT FROM AUTHOR]

Objective. To elicit women's personal understanding of future cardiovascular risk, following a pregnancy complicated by preeclampsia, and to identify the postnatal needs of these women. Methods. Semi-structured interviews with 12 women with a recent history of preeclampsia who had attended a postnatal follow-up clinic. Results. The interviews were held at a median of 47 weeks postpartum (range 24-62 weeks). Family history of cardiovascular disease was associated with a greater awareness of future cardiovascular risk. Women without traditional risk factors found it hard to envisage themselves as being at risk and may not see the relevance of such information. It may take several months after delivery for a woman to be able to fully consider her own health as well as the baby's; a reminder of risk and health information is needed. Conclusions. Although receptive to follow-up, the situational factors of being a new mother need to be taken into account to engage successfully with this patient group. Further research is needed to help clarify the extent to which a history of preeclampsia is an independent factor for future cardiovascular disease to provide a solid foundation for effective risk communication. [ABSTRACT FROM AUTHOR]

An abstract of the medical research "Control of human trophoblast invasion: The role of transforming growth factor beta 1 and 2" is presented. It states that trophoblast invasion and transformation of the maternal spiral arteries are fundamental in a successful pregnancy. It discusses the hypothesis of the study and highlights the conclusions obtained.

An abstract of the medical research "Ultrasound-guided placental bed biopsy in the first and second trimester" is presented. It explains that the study aimed to determine whether adequate samples of the placental bed could be obtained transcervically with the use of biopsy forceps. It also mentions the use of ultrasound to determine gestational age and placental location.

The article presents an abstract of the research paper "Integrin expression at the first and second trimester feto-maternal interface," by E. Ball, F. Lyall, and J.N. Bulmer. The research systematically studied integrin distribution in trophoblast in placental bed biopsies. The placental bed biopsies data were taken from 45 women undergoing abortion. The results shows that variations in integrin expression may reflect differing invasive potential of subpopulations of interstitial trophoblast.